(Q41089111)

26 September 2017

title

Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells (English)

1 reference

26 September 2017

Sun L

1

1 reference

26 September 2017

Chen C

series ordinal

2

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Journal of Biological Chemistry

26 September 2017

published in

1 reference

26 September 2017

volume

272

1 reference

26 September 2017

issue

40

1 reference

26 September 2017

page(s)

25367-25372

1 reference

TGF beta signals through a heteromeric protein kinase receptor complex

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

TGFbeta signaling: receptors, transducers, and Mad proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Binding of transforming growth factor-beta to cell surface proteins varies with cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Expression cloning and characterization of the TGF-beta type III receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

c-myc and pRB: role in TGF-beta 1 inhibition of keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Transcripts for transforming growth factors in human breast cancer: clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Heterogeneity of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Transforming growth factors and the regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Tumor suppressor activity of the TGF-beta pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Growth factor expression in Breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Expression of transforming growth factor-beta 1 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Preparation and binding of radioactively labeled porcine transforming growth factor type beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.40.25367

21 January 2018

Identifiers

DOI

10.1074/JBC.272.40.25367

1 reference

26 September 2017

1 reference